World's Best Scientists 2026 revealed!
Award Badge
Molecular Biology
Czechia
2026
Award Badge
Genetics and Molecular Biology
Czechia
2024

D-Index & Metrics

Molecular Biology

D-Index
69
Citations
17828
World Ranking
1471
National Ranking
3

Pavel Vodicka publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Pavel Vodicka sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 333 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Pavel Vodicka D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Pavel Vodicka sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 69 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in Czechia Leader Award
  • 2025 - Research.com Molecular Biology in Czechia Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in Czechia Leader Award
  • 2023 - Research.com Genetics and Molecular Biology in Czechia Leader Award
  • 2022 - Research.com Genetics and Molecular Biology in Czechia Leader Award

Overview

Pavel Vodicka is affiliated with the Czech Academy of Sciences in the Czech Republic. Their research primarily focuses on biochemistry, genetics, and molecular biology, with significant contributions to medicine.

The main fields of study for Pavel Vodicka include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these fields, their work spans several subfields such as molecular biology, cancer research, genetics, oncology, and pathology and forensic medicine.

  • Molecular Biology
  • Cancer Research
  • Genetics
  • Oncology
  • Pathology and Forensic Medicine

The core topics addressed in their research involve:

  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Genetic Associations and Epidemiology
  • Cancer-related molecular mechanisms research
  • DNA Repair Mechanisms
  • Pancreatic and Hepatic Oncology Research
  • Epigenetics and DNA Methylation

Pavel Vodicka has a notable publication record with recent papers including:

  • Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis (2020) published in Nature Communications
  • Minimum Information for Reporting on the Comet Assay (MIRCA): recommendations for describing comet assay procedures and results (2020) published in Nature Protocols
  • Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk (2020) published in The American Journal of Human Genetics
  • Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study (2020) published in BMC Medicine
  • Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis (2022) published in JNCI Journal of the National Cancer Institute

Frequently, Pavel Vodicka collaborates with several co-authors including Ľudmila Vodičková, Hermann Brenner, Veronika Vymetálková, Andrea Gsur, and Ulrike Peters, reflecting ongoing research partnerships.

  • Ľudmila Vodičková
  • Hermann Brenner
  • Veronika Vymetálková
  • Andrea Gsur
  • Ulrike Peters

The scientist's work is often published in journals such as Cancer Research, Mutagenesis, bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Oncology, and the International Journal of Molecular Sciences.

  • Cancer Research
  • Mutagenesis
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Oncology
  • International Journal of Molecular Sciences

Best Publications

  • 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future

    Sona Vodenkova;Tomas Buchler;Klara Cervena;Veronika Veskrnova

  • A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3

    Ian P.M. Tomlinson;Emily Webb;Luis Carvajal-Carmona;Peter Broderick

  • Discovery of common and rare genetic risk variants for colorectal cancer

    Jeroen R. Huyghe;Stephanie A. Bien;Tabitha A. Harrison;Hyun Min Kang

  • Minimum Information for Reporting on the Comet Assay (MIRCA): recommendations for describing comet assay procedures and results

    Peter Møller;Amaya Azqueta;Elisa Boutet-Robinet;Gudrun Koppen

  • Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer

    Debora Landi;Federica Gemignani;Alessio Naccarati;Barbara Pardini

  • Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

    Brian M. Wolpin;Cosmeri Rizzato;Peter Kraft;Charles Kooperberg

  • Natural compounds and combination therapy in colorectal cancer treatment

    A. Rejhová;A. Rejhová;A. Opattová;A. Čumová;D. Slíva

  • PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome.

    Barbara Schormair;David Kemlink;Darina Roeske;Gertrud Eckstein

  • Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA

    Pavel Vodicka;Rajiv Kumar;Rajiv Kumar;Rudolf Stetina;Somali Sanyal

  • HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.

    Miroslav Svoboda;Jana Slyskova;Michaela Schneiderova;Peter Makovicky

  • Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer

    Erica J Childs;Evelina Mocci;Daniele Campa;Daniele Campa;Paige M Bracci

  • The role of ABC transporters in progression and clinical outcome of colorectal cancer.

    I. Hlavata;B. Mohelnikova-Duchonova;R. Vaclavikova;V. Liska

  • Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects.

    Pavel Vodicka;Rudolf Stetina;Veronika Polakova;Elena Tulupova

  • Lifestyle and dietary environmental factors in colorectal cancer susceptibility.

    Neil Murphy;Victor Moreno;David J. Hughes;Ludmila Vodicka

  • Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

    Alison P. Klein;Brian M. Wolpin;Harvey A. Risch;Rachael Z. Stolzenberg-Solomon

  • Circulating biomarkers for early detection and clinical management of colorectal cancer.

    María Marcuello;Veronika Vymetalkova;Rui P.L. Neves;Saray Duran-Sanchon

  • Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis.

    Barbara Schormair;Chen Zhao;Steven Bell;Erik Tilch

  • Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.

    Juliane Winkelmann;Darina Czamara;Barbara Schormair;Franziska Knauf

  • Discovery of common and rare genetic risk variants for colorectal cancer

    Jeroen R. Huyghe;Stephanie A. Bien;Tabitha A. Harrison;Hyun Min Kang

  • Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis

    Barbara Schormair;Chen Zhao;Steven Bell;Erik Tilch

Frequent Co-Authors

Ludmila Vodickova
Ludmila Vodickova Charles University
Kari Hemminki
Kari Hemminki Charles University
Federico Canzian
Federico Canzian German Cancer Research Center
Graham G. Giles
Graham G. Giles University of Melbourne
Hermann Brenner
Hermann Brenner German Cancer Research Center
Stefano Landi
Stefano Landi University of Pisa
Polly A. Newcomb
Polly A. Newcomb Fred Hutchinson Cancer Research Center
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Sergi Castellví-Bel
Sergi Castellví-Bel Clínic Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology opens doors to various career pathways in healthcare and the life sciences. Many students also consider complementary fields such as nursing, psychiatric care, or health services — all of which offer robust online degree options.

For those interested in transitioning into healthcare quickly, accelerated nursing programs for non nurses online provide a fast and flexible route to earning a nursing degree, even for those with non-nursing backgrounds. Nurses looking to advance their education can benefit from a 6 month rn to bsn program, significantly expediting their academic journey.

If becoming a nurse practitioner is your goal, it's worth learning how long does it take to become a nurse practitioner, as multiple pathways with differing time frames are available. In addition, fields like psychiatric nursing can be rewarding both financially and professionally — you can find up-to-date information about psychiatric np salary to help guide your decision.

Combining Molecular Biology with online healthcare degrees can diversify your career prospects and prepare you for emerging opportunities in medicine, research, and advanced clinical roles.

Best Scientists Citing Pavel Vodicka

Trending Scientists

Recently Published Articles